CALA   $0.3401  -10.93% Market Closed

Calithera Biosciences Inc
Total Cash 25.45M
totalCashPerShare 5.223
EBITDA -41.82M
Total Debt 1.67M
quickRatio 3.444
currentRatio 3.603
Total Revenue
debtToEquity 8.17
Revenue/Share
ROA -0.5629
ROE -1.1414
grossProfits
freeCashflow -28.17M
operatingCashflow -43.61M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -1.44M
forwardPE
floatShares 4.78M
sharesOutstanding 4.87M
sharesShort 417.28K
sharesShortPriorMonth 148.51K
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.0
Short Ratio help_outline 0.78%
shortPercentOfFloat 0.09%
impliedSharesOutstanding
bookValue -0.401
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -21.29M
trailingEps -7.94%
forwardEps -1.35%
enterpriseToEbitda 0.03
lastDividendValue
lastDividendDate
currentQuarterEstimate 4Q 2022
institutionsCount 0
lastUpdated Oct. 16, 2024, 12:34 p.m.